Sinovac Biotech logo

SVA - Sinovac Biotech News Story

$6.47 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £361.3m
Position in Universe th / 6846

UPDATE 1-Thailand approves Johnson & Johnson's COVID-19 vaccine

Thu 25th March, 2021 11:23am
(Adds details about other vaccine requests)
    BANGKOK, March 25 (Reuters) - Thailand has granted emergency
authorisation to Janssen, the single-dose coronavirus vaccine of
Johnson & Johnson  JNJ.N , the country's health minister said on
Thursday, the third vaccine to be cleared for local use. 
    Anutin Charnvirankul told reporters the Food and Drug
Administration (FDA) had approved the vaccine, in addition to
those of AstraZeneca  AZN.L  and Sinovac Biotech  SVA.O , which
have already been administered in the country.  
    J&J's vaccine is called COVID Vaccine Janssen after the J&J
unit that developed it.
    China's Sinopharm and the makers of Russia's Sputnik V and
are preparing to submit requests for approval, Paisal Dunkhum
head of Thailand's FDA said. 
    Moderna  MRNA.O  has said it would submit an application for
approval while India's Bharat Biotech is in the process
submitting documents for vaccine registration, Paisal said.
 urn:newsml:reuters.com:*:nL4N2L92T4
    Thailand, which has recorded just over 28,000 coronavirus
cases overall, has administered about 100,000 doses of vaccines
among medical workers and high-risk groups so far.
    It's main vaccine drive is expected to start in June, using
locally-produced AstraZeneca shots and it plans to inoculate
half of its adult population by the end of the year. 

 (Reporting by Chayut Setboonsarng Panarat Thepgumpanat; Editing
by Martin Petty)
 ((martin.petty@tr.com; +66 89 607 0413))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.